Abstract
Pure red cell aplasia developed in a patient with small-cell lung cancer who was also taking sustained-release procainamide. Shortly after discontinuation of the procainamide preparation, a reticulocytosis and increasing hemoglobin level were observed.
Publication types
-
Case Reports
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Aged
-
Anemia, Aplastic / chemically induced*
-
Carcinoma, Small Cell / drug therapy
-
Delayed-Action Preparations
-
Drug Therapy, Combination
-
Humans
-
Lung Neoplasms / drug therapy
-
Male
-
Myocardial Infarction / drug therapy
-
Procainamide / administration & dosage
-
Procainamide / adverse effects*
Substances
-
Delayed-Action Preparations
-
Procainamide